摘要
目的:探讨艾迪注射液联合放疗治疗肺癌的近期疗效和不良反应。方法:2008年7月-2012年4月102例肺癌患者分为对照组(62例)和治疗组(40例),对照组患者单纯接受放疗,治疗组患者在放疗的基础上联合应用艾迪注射液。观察两组的近期疗效和不良反应。结果:治疗组治疗有效率为60.0%,明显高于对照组(P<0.05);治疗组骨髓抑制、放射性肺炎的发生率明显低于对照组(P<0.05)。结论:艾迪注射液联合放疗治疗肺癌,可提高近期疗效并减轻放疗副作用,可改善肺癌患者的生活质量。
Objective：To investigate the recent therapeutic effects of Aidi injection combined with radiotherapy for treating lung cancer.Methods：102 lung cancer patients from 2008.7 to 2012.4 were divided into control group （n=60） and treatment group （n=40）. The patients in control group were treated with radiotherapy only, while the patients in treatment group were treated with Aidi injection combined with radiotherapy. The recent therapeutic effects and adverse reactions of these 2 groups were observe＆Results：The effective rate of treatment group was 60.0%, which was obviously higher than that of control group （P〈 0.05）. The incidence of bone marrow depression and radiation pneumonitis of treatment group were obviously lower than that of conlrol group （P〈 0.05）.Condusions：Aidi injection combined with mdiotherapy for treating lung cancer can improve recent therapeutic effects and reduce side effects of radiotherapy, so can inpove the life quality of lung cancer patients.
出处
《承德医学院学报》
2013年第1期25-27,共3页
Journal of Chengde Medical University
关键词
肺癌
艾迪注射液
放疗
疗效
Lung cancer
Aidi injection
Radiotherapy
Therapeutic effect
